Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the symptomatic relief of diarrhea predominant irritable bowel syndrome (IBS-D). METHODS: A total of 20 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://www.ncbi.nlm.nih.gov/pubmed/22837880
http://dx.doi.org/10.5056/jnm.2012.18.3.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://www.ncbi.nlm.nih.gov/pubmed/22837880
http://dx.doi.org/10.5056/jnm.2012.18.3.317

Ejemplares similares